108 yuan → 18 yuan!The seventh batch of national pricking medicines available in November

Another wave of price reduction is here!

On the 12th, the seventh batch of national organizational drugs were purchased in Nanjing, Jiangsu.

Including common diseases, chronic diseases such as hypertension, diabetes, anti -infection, digestive tract diseases, and major diseases such as lung cancer, liver cancer, kidney cancer, and bowel cancer.

60 kinds of drug procurement successfully

The average price reduction is 48%

The collection of 60 drugs in this collection is successful. The average price reduction of drugs is planned to be selected by 48%. According to the agreed purchase volume, it is expected to save 18.5 billion yuan per year.

The collection of drugs mainly includes common diseases such as hypertension, diabetes, anti -infection, and digestive tract diseases, as well as major diseases such as lung cancer, liver cancer, kidney cancer, and bowel cancer.

In the end, the 327 products of 217 companies were qualified for the selection, with 73%of the company's selection.

Experts said that of the 60 drugs that have been successfully purchased, more than 20 large varieties of over 1 billion were involved.

Chang Feng, Dean of the International Medical Business School of China Pharmaceutical University: 28 companies participated in Omeprazole (gastritis) and 10 were selected. This is one of the most competitive varieties in this group.

The first collection of consequences is introduced to the preparation mechanism for the first time. Each province will also have a main company and a preparation enterprise at the same time to ensure clinical needs.

Gu Hai, director of the Nanjing University Health Policy and Management Research Center: If the main supply enterprises have occurred during the supply process, or in the performance of the agreement, it will be supplemented by the company. This can ensure that our medicines can stabilize the clinic and serve the people.

National patients in November this year

Pharmaceuticals after available prices

Which drugs are reduced in this national collection? When can patients across the country use drugs after the price reduction?

This episode involves 31 treatment categories. Taking the first -line liver cancer -targeted Yaolilunkini Capsule, it dropped from 108 yuan to an average of 18 yuan. Anti -virus drug Oasievil, which treats influenza, drops from average 4.5 yuan to 1 yuan per tablet.

Zhang Jie, deputy director of the National Organization Purchase Office: Many drugs are good medicines commonly used by ordinary people. For example, for the first time in the antihypertensive field, it is included in the slow -controlled release dosage form, such as 58%reduction in the price of nifed nitzhenphenylene. The price reduction will be significantly reduced.

Since the establishment of the State Medical Insurance Bureau in 2018, it has carried out 7 batches of national organizational procurement of drugs, covering a total of 294 kinds of drugs, and the average decrease of drug prices has decreased by more than 50%.

Zhang Jie, deputy director of the National Organization of Pharmaceutical Co -Purchasing Office: In the next step, the State Medical Insurance Administration will instruct relevant departments to guide all localities and selected enterprises to do the implementation of the selection results to ensure that patients across the country can use the price reduction in November 2022 after the price reduction reduction reduction. These secondary products.

What are the changes in the collection rules?

The centralized procurement of drugs in the country is popular in general to organize large -scale drugs to "group purchase" in various provinces and regions of the country to reduce the price of drugs through the method of "replacement of price".

Since its launch in November 2018, the National Organization Pharmaceutical Collection has completed six batches of 234 drugs, with an average of 53%of the drug prices, which involved 30%of the total annual drug procurement of public medical institutions, and saving medical expenses of 260 billion yuan Above, the burden on the masses is effectively alleviated.

What are the changes in the collection rules? From the perspective of the seventh batch of varieties reporting methods and decreased proportions of the proportion of quantities, in practice, the operation method has been further standardized and refined.

Make the results of the collection of collection more operable, and more fit the actual market use of the variety.

Pharmaceutical collection is in exchange for the actual clinical needs of medical institutions in exchange for pharmaceutical companies to provide drugs at lower prices.

Therefore, the varieties of each collection and the purchase volume of each variety will also be adjusted according to clinical needs.

Yue Xiaolin, Secretary of the Party Committee of the Xuanwu Hospital of the Capital Medical University and the Party Committee of Xuanwu Hospital of the Capital Medical University: There is a very big change in the variety with the varieties, that is, the number of ordinary antibiotics is 10%lower than ordinary medicines, which reflects us on us, which reflects us on us, which reflects us on us The rules of national drug concentrated with volume procurement are continuously improved in accordance with the changes in the market and disease spectrum.

Different from the past, the seventh batch of national opticals changed the rules of "only one bidding enterprise in one province in one province" in the seventh batch of national minions, and added the concept of regional and alternative enterprises to ensure that the drugs can be stable.

As the number of companies selected in the collection varieties continues to increase, supply guarantee is an important prerequisite.

In order to prevent the confession of pharmaceutical companies, the drug collection has increased the regional and alternative enterprises in terms of rules. When the main supply enterprise cannot meet the market demand of the selected areas, the provided enterprise can obtain the owner's supply in accordance with the relevant procedures to obtain the main supply of the Lord's supply in accordance with the relevant procedures. Corporate identity.

Gu Hai, director of Nanjing University Health Policy and Management Research Center: A medicine, then choosing a company is the main supply. The second is to prepare for the company. If the main supply enterprise has occurred in the supply process, some situations have occurred in the supply agreement, then it is melted, and then the supply of enterprises will come up. This can ensure that our drugs can provide clinical clinics stably and serve the people.

This collection also requires the domestic effective registration approval period that continues to have the selected drugs during the performance of the China Enterprise, which further strengthened the responsibility for the performance of the Chinese -elected enterprise.

The National Medical Insurance Bureau stated that it will adhere to the "zero tolerance" attitude for effective registered approval malicious and random transfer, as well as the phenomenon of the siege behind it.

The collection is clear, and it is judged as "serious" or "particularly serious" level of dishonesty or the selection of varieties in the two -year collection.Among them, none of them have the qualifications for the first choice of confirmation, that is, a relatively few supply regions, this rule further deepen the application strength and intensity of the recruitment credit system.Source: CCTV Finance, CCTV.com, etc.

- END -